as OVF mentioned yesterday.... 10 patients study is completely fine for a rare disease
and as DoctorBrad mentioned above.... results are better than Sparsentan ....
either u purposely trying to spread misinformation or u clearly have no idea what u talking about ...
in both cases.... it doesn't help ..
how the market reacts no one knows .... but results are positive and I mean very positive
Ann: Positive Top-Line Results in FSGS Phase 2a Clinical Study, page-49
-
- There are more pages in this discussion • 238 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
-0.020(4.60%) |
Mkt cap ! $228.5M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 43.5¢ | 41.0¢ | $731.5K | 1.748M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 269178 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 14070 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |